MDD Exec

A new website has been launched considering the increasing demand for transradial education in the U.S.

Boston Scientific has shared that the Circulatory System Devices Panel of the U.S. Food and Drug Administration (FDA) has unanimously recommended approval of an expanded indication for its cardiac resynchronisation therapy defibrillators (CRT-Ds), including the COGNIS CRT-D.

It has emerged that several medical device makers are being investigated by the U.S. Justice Department over the marketing of surgical-ablation devices.

The U.S.

The U.S. Food and Drug Administration (FDA) is soliciting comments from interested persons on ways in which it can increase transparency between the FDA and regulated industry.

R-Squared has formed a strategic alliance with IMS Health to help pharmaceutical and medical device manufacturers comply with the growing body of state transparency and marketing disclosure laws, known as “aggregate spend” reporting laws.